|
Magyar Élet- és Egészségbiztosítási Orvostani Társaság |
|
ICLAM 2013 Madrid |
Rendezvény kezdete: 2011.05.26. | Rendezvény vége: 2011.05.29. |
Helyszín: Spain, 28020 Madrid, Calle del Capitán Haya 43, Hotel Meliá Castilla |
A rendezvény Web oldala: https://congress.iclam.org/ |
Every three years ICLAM organizes a Life, Disability and Health Assurance Medicine meeting with worldwide acknowledgment and participation. The aim of this prestigious event is to address topics related to medical and surgical treatments and advances which will have an impact on insurance medicine. This provides insurance professionals a sound and updated knowledge of all new trends and scenarios that will be useful for them in their daily work.
Venue:
Hotel Meliá Castilla
Calle del Capitán Haya 43
Madrid, MD 28020, Spain
Phone: +34 902 144 440
http://www.meliacastilla.com |
|
|
|
|
Magyar Élet- és Egészségbiztosítási Orvostani Társaság |
|
ICLAM 2013 Madrid |
Rendezvény kezdete: 2011.05.26. | Rendezvény vége: 2011.05.29. |
Helyszín: Spain, 28020 Madrid, Calle del Capitán Haya 43, Hotel Meliá Castilla |
A rendezvény Web oldala: https://congress.iclam.org/ |
Every three years ICLAM organizes a Life, Disability and Health Assurance Medicine meeting with worldwide acknowledgment and participation. The aim of this prestigious event is to address topics related to medical and surgical treatments and advances which will have an impact on insurance medicine. This provides insurance professionals a sound and updated knowledge of all new trends and scenarios that will be useful for them in their daily work.
Venue:
Hotel Meliá Castilla
Calle del Capitán Haya 43
Madrid, MD 28020, Spain
Phone: +34 902 144 440
http://www.meliacastilla.com |
|
|
|
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|